Industrial, Manufacturing & Heavy Industry Market News

Learn details of the H1 analysis on progressive supranuclear pals review report

Learn details of the H1 analysis on progressive supranuclear pals review report

The Progressive Supranuclear Pals pipeline guide provides a snapshot of the global therapeutic landscape of Progressive Supranuclear Palsy (Central Nervous System).

- Agency -.

The Progressive Supranuclear Palsy pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

Progressive Supranuclear Palsy Pipeline key players are AB Science SA, AbbVie Inc, AlzProtect SAS, Asceneuron SA, Bristol-Myers Squibb Company, Cortice Biosciences Inc, Intellect Neurosciences Inc, K-Stemcell Co Ltd, Merck & Co Inc, Prana Biotechnology Ltd, TauRx Therapeutics Ltd.

Access Complete Report On Progressive Supranuclear Palsy Pipeline Review H1 2017: www.reportsnreports.com/.aspx?name=1057930 .

Progressive supranuclear palsy, also called Steele-Richardson-Olszewski syndrome is a rare neurodegenerative disease that leads to difficulty with balance, movement, vision, speech and swallowing.

- Agency -.

Symptoms include fatigue, headaches, dizziness, depression, Parkinsonism, behavioral, cognitive, and gait disturbances that cause imbalance and arthralgias.

The only proven risk factor for progressive supranuclear palsy is age. Treatment includes anticholinergic medications.

Report: www.reportsnreports.com/contacts/.aspx?name=1057930 .

Progressive Supranuclear Palsy Pipeline H1 2017, provides comprehensive information on the therapeutics under development for Progressive Supranuclear Palsy (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope

The report provides a snapshot of the global therapeutic landscape of Progressive Supranuclear Palsy. The report reviews pipeline therapeutics for Progressive Supranuclear Palsy by companies and universities/research institutes based on information derived from company and industry-specific sources.

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages. The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.

The report reviews key players involved Progressive Supranuclear Palsy therapeutics and enlists all their major and minor projects. The report assesses Progressive Supranuclear Palsy therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

The report summarizes all the dormant and discontinued pipeline projects. The report reviews latest news related to pipeline therapeutics for Progressive Supranuclear Palsy

List of Figures
Number of Products under Development for Progressive Supranuclear Palsy, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products by Top 10 Targets, H1 2017
Number of Products by Stage and Top 10 Targets, H1 2017
Number of Products by Top 10 Mechanism of Actions, H1 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
Number of Products by Routes of Administration, H1 2017
Number of Products by Stage and Routes of Administration, H1 2017
Number of Products by Molecule Types, H1 2017
Number of Products by Stage and Molecule Types, H1 2017

 

News From

ReportsnReports - Industry Trends & ForecastsReportsnReports
Category: Market Research Publishers and RetailersCompany profile: ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision-making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets.